Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli.
In vitro exposure of Gram-negative bacilli (GNB) to antimicrobial agents may induce endotoxin (ET) release, that may cause various reactions in vivo resulting in endotoxic shock. We used the antimicrobial agents, flomoxef (FMOX) and gentamicin (GM), to investigate the kinetics of ET released from in-vitro-cultured Escherichia coli and to examine the ET effect on tumor necrosis factor (TNF) production by macrophages. In a rabbit model of E. coli peritonitis, we measured plasma ET, TNF and blood bacterial counts under the administration of FMOX or GM. In our in vitro experiment, ET levels under FMOX were significantly higher than those under GM, and ET induced TNF production in a dose-dependent manner. However, in vivo, plasma ET, TNF, and blood bacterial counts under antimicrobial agents were significantly lower than those of the controls, and those under FMOX treatment did not differ from those under GM treatment. Thus, ET release may not be a critical problem in GNB infections if appropriate antimicrobial agents are administered.
Tsumura
Hiroaki
H
Department of Surgery, Division of Clinical Medical Sciences, Graduate School of Biomedical Science, Hiroshima University, Hiroshima Municipal Funairi Hospital, 14-11 Funairisaiwai-cho, Naka-ku, 730-0844 Hiroshima, Japan. tuntun1234@hotmail.com
Hiyama
Eiso
E
Kodama
Takashi
T
Sueda
Taijiro
T
Yokoyama
Takashi
T
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004731:Endotoxins / Q000097:blood / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects* / Q000378:metabolism*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000382:microbiology; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004731:Endotoxins; D005839:Gentamicins; D014409:Tumor Necrosis Factor-alpha; C045693:flomoxef